Condensed Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Operating expenses:
Research and development	$ 27,244	$ 25,347	$ 92,845	$ 71,680
General and administrative	6,795	5,772	21,151	17,127
Total operating expenses	34,039	31,119	113,996	88,807
Loss from operations	(34,039)	(31,119)	(113,996)	(88,807)
Interest and other income, net	1,252	2,690	4,872	6,436
Net loss	(32,787)	(28,429)	(109,124)	(82,371)
Other comprehensive loss:
Unrealized gain (loss) on investments, net			0
Comprehensive loss	$ (32,787)	$ (28,429)	$ (109,124)	$ (82,371)
Net loss per common share, basic	$ (0.91)	$ (0.8)	$ (3.03)	$ (2.46)
Net loss per common share, diluted	$ (0.91)	$ (0.8)	$ (3.03)	$ (2.46)
Weighted-average number of common shares used to compute basic net loss per common share	36,220,736	35,653,988	36,052,173	33,551,808
Weighted-average number of common shares used to compute diluted net loss per common share	36,220,736	35,653,988	36,052,173	33,551,808